Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Identification of ST3GAL6-AS1 Interactive Protein in Multiple Myeloma

Ying Shen, MD, Fangmei Li, PhD, Dong Wu, MD, Yue Peng, Wanhong Zhao, MD, Yun Yang, MD, Jianli Wang, MD, Ju Bai, PhD, Yan Xu, Aili He

Blood (2019) 134 (Supplement_1): 4365.

https://doi.org/10.1182/blood-2019-125210

Published: 2019

Journal Articles

Silencing Long Non-Coding RNA ST3GAL6-AS1 Inhibits Adhesion and Migration of Myeloma Cells in Vitro

Ying Shen, MD, Yuandong Feng, MD, Hongli Chen, Yachun Jia, Yue Peng, Ru Zhang, MD, Yun Yang, MD, Jian-Li Wang, MD PhD, Ju Bai, PhD, Fang-Xia Wang, MD PhD, Yan Xu, Jinsong Hu, PhD, Aili He, MD

Blood (2018) 132 (Supplement 1): 4470.

https://doi.org/10.1182/blood-2018-99-114660

Published: 2018

Journal Articles

Robust Bioinformatics Approach for Identifying Novel AML LSC Targets: Putative Role of Galectin-1 in the Immune-Microenvironment

Shelley Herbrich, MS, Peter P. Ruvolo, PhD, Vivian Ruvolo, PhD, Keith Baggerly, PhD, Gheath Alatrash, DO, PhD, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD

Blood (2017) 130 (Supplement 1): 3962.

https://doi.org/10.1182/blood.V130.Suppl_1.3962.3962

Published: 2017

Journal Articles

Role of Mesenchymal Stem Cell Galectin 3 in the AML Tumor Microenvironment

Peter Ruvolo, PhD, Yihua Qiu, MD, Vivian Ruvolo, MS, Rui-Yu Wang, MD PhD, Zhihong Zeng, MD, Jared Burks, PhD, Rongqing Pan, MS, Numsen Hail, Jr., PhD, Teresa McQueen, Suk-Young Yoo, Steven M. Kornblau, MD, Michael Andreeff, MD PhD

Blood (2015) 126 (23): 1198.

https://doi.org/10.1182/blood.V126.23.1198.1198

Published: 2015

Journal Articles

GCS-100 Induces Apoptosis of Acute Myeloid Leukemia Cells By Disrupting Galectin-Mediated Survival Signaling

Richard E. Davis, MD, Vivian R Ruvolo, MA, Zhiqiang Wang, Wencai Ma, PhD, Wendy D. Schober, MLT (ASCP), James Rolke, George Tidmarsh, MD PhD, Michael Andreeff, MD PhD, Peter P. Ruvolo, PhD

Blood (2014) 124 (21): 904.

https://doi.org/10.1182/blood.V124.21.904.904

Published: 2014

Journal Articles

Mesenchymal Stromal Cells Suppress T-and B-Cells via Galectin-9 in a Donor Dependent Manner

Christopher Ungerer, Patricia Quade-Lyssy, Reinhard Henschler, Erhard Seifried, MD, PhD, Heinfried Radeke, Joerg Schuettrumpf, MD

Blood (2012) 120 (21): 1248.

https://doi.org/10.1182/blood.V120.21.1248.1248

Published: 2012

Journal Articles

Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma

Filiberto Cedeno-Laurent, Rei Watanabe, Jessica E. Teague, Thomas S. Kupper, Rachael A. Clark, Charles J. Dimitroff

Blood (2012) 119 (15): 3534–3538.

https://doi.org/10.1182/blood-2011-12-396457

Published: 2012

Includes: Supplemental data

Journal Articles

Galectin-9 Overcomes Various Types of Treatment Resistance through ATF-3/Noxa Pathway-Mediated Apoptosis In Chronic Myelogenous Leukemia

Junya Kuroda, MD, PhD, Mio Yamamoto, Hisao Nagoshi, Tsutomu Kobayashi, Nasa Sasaki, Yuji Shimura, Shigeo Horiike, Shinya Kimura, Mitsuomi Hirashima, Masafumi Taniwaki, MD, PhD

Blood (2010) 116 (21): 4930.

https://doi.org/10.1182/blood.V116.21.4930.4930

Published: 2010

Journal Articles

Tim-3, a Novel Immune Receptor, Is Constitutively Expressed on Human Natural Killer Cells and Functions as An Activating Coreceptor

Michelle Gleason, Todd Lenvik, Valarie McCullar, Sarah Cooley, MD, Michael Verneris, MD, Toshiro Niki, Mitsuomi Hirashima, Bruce R. Blazar, MD, Jeffrey S. Miller, MD

Blood (2010) 116 (21): 106.

https://doi.org/10.1182/blood.V116.21.106.106

Published: 2010

Journal Articles

Anti-Myeloma Activity of Modified Galectin-9 through JNK and p38 MAPK Pathways.

Tsutomu Kobayashi, Junya Kuroda, MD, PhD, Eishi Ashihara, MD, PhD, Yasuhito Terui, MD, PhD, Souichi Oomizu, Mio Yamamoto, Akiko Taniyama, Yosuke Matsumoto, Shigeo Horiike, Kiyohiko Hatake, MD, PhD, Akira Yamauchi, MD, PhD, Mitsuomi Hirashima, MD, PhD, Masafumi Taniwaki, MD, PhD

Blood (2009) 114 (22): 952.

https://doi.org/10.1182/blood.V114.22.952.952

Published: 2009

Journal Articles

Galectin-9 Ameriorates Acute GVHD by Inducing T-Cell Apoptosis and Increasing Regulatory T Cell.

Kazuki Sakai, MD, Eri Kawata, MD, PhD, Eishi Ashihara, MD, PhD, Akira Yamauchi, MD, PhD, Shinya Kimura, MD, PhD, Hideyo Hirai, MD, PhD, Mitsuomi Hirashima, MD, PhD, Norio Yoshimura, MD, PhD, Taira Maekawa, MD, PhD

Blood (2009) 114 (22): 1338.

https://doi.org/10.1182/blood.V114.22.1338.1338

Published: 2009

Journal Articles

Bone Marrow Osteoclasts Stain Positive with X-Gal: Implications for the Tracking of LacZ-Labelled Cells.

Hans-Georg Kopp, MD, Andrea T. Hooper, BS, Shahin Rafii, MD

Blood (2006) 108 (11): 4173.

https://doi.org/10.1182/blood.V108.11.4173.4173

Published: 2006

Journal Articles

Expression and Modulation of Carbohydrate-Binding Protein Galectin-3 in Multiple Myeloma Cells by Combined Treatment with GCS-100 and Dexamethasone.

Dharminder Chauhan, PhD, Yan Chang, Ph.D, Deli He, M.S, Teru Hideshima, MD, Ph.D, Klaus Podar, M.D, Florence Tao, Ph.D, Paola Neri, M.D, Robert Schlossman, M.D, Joanne Schindler, M.D, Bradley Carver, M.D, Paul Richardson, M.D, Kenneth C. Anderson, M.D

Blood (2005) 106 (11): 4447.

https://doi.org/10.1182/blood.V106.11.4447.4447

Published: 2005

Journal Articles

Galectin-1 Is Overexpressed in Myeloid Cells and There Is a Significant Different Overexpression in Cells Carrying the BCR-ABL Chimeric Gene.

Enrica Lerma, MD, PhD

Blood (2005) 106 (11): 4383.

https://doi.org/10.1182/blood.V106.11.4383.4383

Published: 2005

Journal Articles

Galectin-1 Can Support the Survival of Human Myeloma Cells in In Vitro Culture.

Saeid Abroun, MD, Fu-Jun Li, MD, Naohiro Tsuyama, Karim Shamsasenjan, Hideki Asaoku, Toshikazu Gondo, MD, Michio M. Kawano, MD

Blood (2005) 106 (11): 2499.

https://doi.org/10.1182/blood.V106.11.2499.2499

Published: 2005

Journal Articles

The SH3 Domain of Alpha Spectrin Binds to Galectin-1 during Erythroid Differentiation.

Paulo R.M. Lima, PhD, Mariana O. Baratti, BSc, Daniela S. Basseres, PhD, Adriana S.S. Duarte, MSc, Fernando F. Costa, PhD, Sara T.O. Saad, PhD

Blood (2005) 106 (11): 1666.

https://doi.org/10.1182/blood.V106.11.1666.1666

Published: 2005

Journal Articles

Galectin-1 Purified from Human Platelets.

Nilda Ester Fink, PhD, Mariana M. Gonzalez, BS

Blood (2005) 106 (11): 3936.

https://doi.org/10.1182/blood.V106.11.3936.3936

Published: 2005

Journal Articles

GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.

Finbarr E. Cotter, MD PhD, Bo Su, MD, Margherita Corbo, BSc, Y. Chang, Joanne Schindler, Brad Carver, Christopher D. Fegan, MD, Adrian C. Newland, MD, Rebecca L. Auer, MD PhD

Blood (2004) 104 (11): 3286.

https://doi.org/10.1182/blood.V104.11.3286.3286

Published: 2004

NARROW

Identification of ST3GAL6-AS1 Interactive Protein in Multiple Myeloma

Silencing Long Non-Coding RNA ST3GAL6-AS1 Inhibits Adhesion and Migration of Myeloma Cells in Vitro

Robust Bioinformatics Approach for Identifying Novel AML LSC Targets: Putative Role of Galectin-1 in the Immune-Microenvironment

Role of Mesenchymal Stem Cell Galectin 3 in the AML Tumor Microenvironment

GCS-100 Induces Apoptosis of Acute Myeloid Leukemia Cells By Disrupting Galectin-Mediated Survival Signaling

Mesenchymal Stromal Cells Suppress T-and B-Cells via Galectin-9 in a Donor Dependent Manner

Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma

Galectin-9 Overcomes Various Types of Treatment Resistance through ATF-3/Noxa Pathway-Mediated Apoptosis In Chronic Myelogenous Leukemia

Tim-3, a Novel Immune Receptor, Is Constitutively Expressed on Human Natural Killer Cells and Functions as An Activating Coreceptor

Anti-Myeloma Activity of Modified Galectin-9 through JNK and p38 MAPK Pathways.

Galectin-9 Ameriorates Acute GVHD by Inducing T-Cell Apoptosis and Increasing Regulatory T Cell.

Bone Marrow Osteoclasts Stain Positive with X-Gal: Implications for the Tracking of LacZ-Labelled Cells.

Expression and Modulation of Carbohydrate-Binding Protein Galectin-3 in Multiple Myeloma Cells by Combined Treatment with GCS-100 and Dexamethasone.

Galectin-1 Is Overexpressed in Myeloid Cells and There Is a Significant Different Overexpression in Cells Carrying the BCR-ABL Chimeric Gene.

Galectin-1 Can Support the Survival of Human Myeloma Cells in In Vitro Culture.

The SH3 Domain of Alpha Spectrin Binds to Galectin-1 during Erythroid Differentiation.

Galectin-1 Purified from Human Platelets.

GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only